The Cleveland Clinic says they have “successfully implanted a dual cardiac device in the first patient in the world as part of a clinical trial, which aims to potentially treat heart failure symptoms.”
Details were announced Thursday morning as Cleveland Clinic officials said this INTEGRA-D clinical study will be used to evaluate the safety and effectiveness of a device that combines two proven cardiac therapies into one.
“Cardiac contractility modulation works to improve the contraction of the heart, while an implantable cardioverter defibrillator treats life-threatening arrhythmias that cause sudden cardiac death,” according to a Cleveland Clinic press release.
The Cleveland Clinic says the Centers for Disease Control and Prevention reports heart failure impacts an estimated 6.2 million Americans.
READ MORE: [ Ссылка ]
At 3News, we’re not here to tell you the news, we’re here to share the stories that you say matter most to you. Share your ideas, thoughts, concerns and engage in conversations about the communities in which we all call home.
Follow 3News on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Visit our site: [ Ссылка ]
And be sure to download our app here: [ Ссылка ]
